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Abstract
The androgen receptor (AR) cofactor p44/WDR77, which regulates expression of a set of androgen target genes, is required
for differentiation of prostate epithelium. Aberrant localization of p44/WDR77 in the cytoplasm is associated with prostate
tumorigenesis. Here, we describe studies that used the mouse prostate and human prostate cancer cells as model systems
to investigate signals that control subcellular localization of p44/WDR77. We observed distinct subcellular location of p44/
WDR77 during prostate development. p44/WDR77 localizes in the cytoplasm at the early stage of prostate development,
when prostate epithelial cells are rapidly proliferating, and in the nucleus in adult prostate, when epithelial cells are fully
differentiated. Subcellular localization assays designed to span the entire open-reading frame of p44/WDR77 protein
revealed the presence of two nuclear exclusion signal (NES) and three nuclear localization signal (NLS) sequences in the p44/
WDR77 protein. Site-directed mutagenesis of critical residues within an NLS led to loss of nuclear localization and
transcriptional activity of p44/WDR77, suggesting that nuclear localization of p44/WDR77 is essential for its function as a
transcriptional cofactor for AR. Three identified NLS were not functional in AR-positive prostate cancer (LNCaP and 22RV1)
cells, which led to localization of p44/WDR77 in cytoplasm. The function of NLS in LNCaP cells could be restored by factor(s)
from Cos 7 or PC3 cells. Mass spectrometric (MALDI-TOF/TOF) analysis identified proteins associated with an NLS and an NES
in prostate cancer cells. These results provide a basis for understanding subcellular transport of p44/WDR77 during prostate
development and tumorigenesis.
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Introduction
The p44/WD77 protein contains 342 amino acid residues and
seven putative WD-40 repeats, interacts with androgen receptor
(AR), and regulates expression of a set of androgen target genes in
the prostate gland and in prostate cancer [1–4]. Prostate glands
from p44/WDR77-deficient mice were smaller than those from
wild-type mice, had fewer branches and terminal duct tips, and
were deficient in production of secretory proteins [4]. In the p44/
WDR77-null prostate, epithelial cells were not fully differentiated,
and expression of androgen-regulated genes was altered. These
results demonstrate that p44/WDR77 acts as an AR cofactor,
playing important roles in prostate growth and differentiation by
modulating AR target gene expression.
Immunohistochemical staining of prostate specimens showed
that the p44/WDR77 protein localizes in the nucleus of benign
epithelial cells and in the cytoplasm of prostate cancer cells [2].
Translocation of p44/WDR77 from the nucleus to the cytoplasm
occurs in prostatic intraepithelial neoplasia and prostate cancer
lesions [2,3]. Forced nuclear localization of p44/WDR77 inhibited
growth of prostate cancer cells in tissue culture [2] and completely
abolished growth of prostate tumor xenografts in nude mice [3].
This growth inhibition was associated with upregulation of p21
and p27 gene expression; downregulation of cyclin A, cyclin B, and
CDK2 gene expression; and cell cycle arrest at the G1/G0 phase
[2,3]. Thus, p44/WDR77’s function is regulated by its subcellular
localization.
The protein sequence of p44/WDR77 is identical to that of a
component (MEP50) of the methylosome complex [5] and a
subunit (WD45) of the SMN complex [6]. The methylosome
complex contains PRMT5, pICln, and Sm proteins and mediates
assembly of spliceosomal snRNP [7]. SMN, the protein involved in
spinal muscular atrophy, is part of a complex that contains the Sm
protein and PRMT5. SMN complex is necessary and sufficient for
assembly of UsnRNA [8,9]. The methylosome and SMN
complexes were isolated from cytoplasm of HeLa cells [7,8], and
the p44-containing complex was purified from a HeLa nuclear
extract [1]. p44/WDR77 forms distinct complexes with various
proteins, suggesting that it may have multiple roles.
Nuclear transport is proving to be a fundamental and critical
mechanism for regulating protein localization and function.
Deregulation of nuclear transport is implicated in the mislocaliza-
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mistargeting of tumor suppressors can have dire cellular
consequences that potentially lead to initiation and progression
of cancer [11]. Protein transport in either direction across the
nuclear envelope involves sequential steps, including (i) recognition
of the protein import/export signal by an import/export receptor,
(ii) docking of the protein/receptor assembly at the nuclear pore
complex, (iii) release of the transported protein, and (iv) recycling
of transport factors [12]. Although broadly defined, each of these
steps is complex and involves intricate interplay of multiple protein
components and a variety of recognition signals. Some proteins
are not transported constitutively, but rather are imported or
exported in response to signals, thus allowing their regulated
redistribution within the cell. Transport recognition signals include
the nuclear localization signal (NLS) and nuclear exclusion signal
(NES). The basic NLS consists of a short stretch of positively
charged lysine and arginine residues [13,14]. The best-character-
ized NES is the leucine-rich NES; a protein containing this NES is
exported by the export receptor CRM1 [15].
Here we report our observations of subcellular localization of
p44/WDR77 during prostate development. We characterized the
nuclear export and import signals in the p44/WDR77 protein and
found that the p44/WDR77 molecule contains two NES and
three NLS signals. The NLS signals did not function in AR-
positive prostate cancer (LNCaP and 22RV1) cells, which might
explain the localization of p44/WDR77 in the cytoplasm of these
cells. Nuclear localization of p44 is essential for its function as a
cofactor in AR-driven transcription. Our findings indicate that the
mechanisms controlling p44/WDR77 subcellular localization and
function are complicated.
Results
Distinct subcellular localization of p44/WDR77 protein
during prostate development
The p44/WDR77 protein localizes in the nucleus of prostate
epithelial cells [2,4] and is transported into the cytoplasm in
prostate intraepithelial hyperplasia and prostate cancer [2]. We
investigated subcellular localization of p44/WDR77 in epithelial
cells during mouse prostate development. Prostate glands were
dissected from male mice at different ages and sections were
immunostained with the anti-p44/WDR77 antibody (Figure 1, left
panels, in red). The nucleus was counterstained with SYTOX
Green (middle panels, in green). The p44/WDR77 protein
localized in the cytoplasm of epithelial cells 7 days after birth
and during the process of ductal branching morphogenesis (14–21
days after birth) [16]. Translocation of p44/WDR77 to the
nucleus was first observed at age 28 days, and the nuclear
accumulation peaked at age 45 days.
Antibodies to cytoskeletal keratin (CK) subclasses have been
used to study prostate cell differentiation [17]. These studies
demonstrated that changes in level of differentiation are
accompanied by a distinct transition in the expression profiles of
individual keratins. Epithelial cells in the adult prostate could be
characterized as basal cells (CK5
+/CK18
2), luminal cells (CK5
2/
K18
+), or intermediate cells (CK5
+/K18
+). The intermediate cells
are in an intermediate state of differentiation and eventually
differentiate into luminal cells [18]. Sections of prostate glands
were stained with anti-keratin 5 (CK5) antibody. CK5 was
detected in undifferentiated luminal cells (in the prostates of mice
aged less than 28 days) but not in fully differentiated luminal cells
(in the prostates of mice aged more than 32 days) (Figure S1A,
middle panels). CK5 was strongly stained in all basal cells of
prostates of mice aged more than 14 days. Staining of the
proliferation marker Ki67 revealed that a majority (70%) of
prostate epithelial cells were proliferative in mice aged 7 days and
that the proliferation rate decreased dramatically in mice aged 14
to 32 days (Figure S1A, bottom panels; Figure S1B). Epithelial cell
proliferation decreased even further in the prostate of mice aged
45 days. Thus, p44/WDR77 nuclear importation is associated
with decrease of proliferation and functional cytodifferentiation of
epithelial cells, coinciding with expression of prostate-specific
secretory proteins [19–22]. p44/WDR77 nuclear staining re-
mained strong in epithelial cells of adult prostate. Similarly, p44/
WDR77 localized in the cytoplasm of epithelial cells in the human
fetal prostate gland and in the nucleus in the adult prostate gland
(P. Lee and Z. Wang, unpublished observations). Thus, transport
of p44/WDR77 from the cytoplasm to the nucleus occurs during
prostate development. In contrast, subcellular localization of AR
did not change during mouse prostate development (Figure S1A,
top panels).
Subcellular localization of p44/WDR77 in various cancer
cell types
Immunostaining and Western blot with the anti-p44/WDR77
antibody revealed that p44/WDR77 is cytoplasmic in AR-positive
prostate cancer LNCaP (Figure 2A, top panels) and 22RV1 cells,
in agreement with our previously reported data [2]. p44/WDR77
protein localizes in both nucleus and cytoplasm of AR-negative
prostate cancer PC3 cells (Figure 2A, middle panels). Similarly, it
is in both cytoplasm and nucleus of monkey fibroblast-like Cos 7
cells (Figure 2A, bottom panels), large T antigen2immortalized
prostate epithelial BPH-1 cells, and other nonprostate cancer cells
(Hela, 293T, and U87) (data not shown).
The N-terminal enhanced green fluorescent protein (GFP)-
tagged p44/WDR77 (GFP-p44) was transiently expressed in
LNCaP cells and, as shown in Figure 2B (top panels), the resulting
GFP-p44 fusion protein had a subcellular localization in those cells
similar to that of the endogenous p44/WDR77 protein (Figure 2A,
top panels). An LNCaP cell line that stably expressed GFP-p44
was established, and the GFP-p44 fusion protein also localized in
the cytoplasm of those cells (Figure 2B, top panel, insert). In
contrast, GFP-p44 accumulated more in the nucleus of the Cos 7
cells (Figure 2B, bottom panels). Control GFP localized in both
nucleus and cytoplasm in Cos 7 (Figure 2B, bottom panel, insert)
and LNCaP cells [2]. Western blot of cytoplasmic and nuclear
fractions further confirmed p44/WDR77 subcellular localization
in these cells (Figure S2).
p44/WDR77 physically interacts with AR (Figure S3) and
regulates AR-driven gene expression [1,2,4]. PC3 and Cos 7 cells
do not express AR, but LNCaP and 22RV1 cells do (Figure S4A).
We investigated whether AR expression influences subcellular
localization of p44/WDR77. We established a stable PC3 cell line
expressing AR (PC3-AR) (Figure S4A, lane 5), but expression of
AR did not affect subcellular localization of p44/WDR77 in these
cells (Figure S5). Similar results were obtained with Cos 7 cells
(data not shown). These results indicate that AR does not directly
involve in subcellular distribution of p44/WDR77. Furthermore,
subcellular localization of p44/WDR77 in LNCaP and PC3-AR
cells was not affected by the presence or absence of an androgen in
the growth medium (Figure S5). In contrast, ligand-dependent
translocation of AR was observed in these cells (Figure S4B). For
reasons that are not clear, the p44/WDR77 physically interacts
with AR but does not transport together with AR during androgen
stimulation. It is more likely that AR in the cytoplasm associates
with molecular chaperons and this interaction prevents its
interaction with p44/WDR77.
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To identify the molecular determinants for subcellular localiza-
tion of p44/WDR77, overlapping fragments spanning the entire
open-reading frame of p44/WDR77 were cloned in frame to
generate pcDNA-f:GFP-p44 fusion constructs. These constructs
were transfected into Cos 7 cells to determine the critical regions of
p44/WDR77 necessary for nuclear export or import.
Two protein fragments, p44(114–278) and p44(278–342), were
found within the cytoplasm in 56% and 75% of transfected cells,
respectively (Figure 3A), suggesting that these fragments contain
Figure 1. p44/WDR77 nuclear translocation during mouse prostate development. Immunostaining of p44/WDR77 (left panels, red) in
prostate glands derived from mice aged 7, 14, 28, 32, or 45 days. The nucleus was counterstained with SYTOX Green (middle panels, green). The
samples were observed under a confocal microscope.
doi:10.1371/journal.pone.0022395.g001
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PLoS ONE | www.plosone.org 3 July 2011 | Volume 6 | Issue 7 | e22395Figure 2. Subcellular localization of p44/WDR77 in cancer cell lines. (A) The p44/WDR77 protein was immunostained with the anti-p44/
WDR77 antibody, and the cell nucleus was counterstained with TO-PRO 3. The samples were observed under a confocal microscope. (B) Cells were
transfected with pcDNA-GFP-p44/WDR77 and observed under a confocal microscope. The cell nucleus was counterstained with TO-PRO 3. Inserts
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amino acid residues from the C-terminal end of the p44(114–278)
fragment enhanced its cytoplasmic localization, indicating that this
region contains an element (NLS3, below) that promotes nuclear
localization. Further deletions from the C-terminal led to gradual
loss of cytoplasmic localization. In contrast, deletion of three
amino acid residues (
114LIV
116) from the N-terminal end of the
p44(114–278) fragment abolished cytoplasmic localization, indi-
cating that these three amino acid residues are critical for
cytoplasmic localization of this fragment. The mutation (L114R/
I115W/V116R) abolished nuclear export of p44(114–278). The
region p44(114–165) was found within the cytoplasm in 95% of
transfected cells (Figure 3A) and is a novel NES, designated NES1
(Figure 4B). NES1 does not resemble the conventional leucine-rich
NES [15].
Deletion of 20 or 58 amino acid residues from the N-terminal
end of the fragment p44(278–342) completely abolished its
cytoplasmic localization (Figure 3A), whereas deletion of 44 amino
acids from the C-terminal end did not decrease cytoplasmic
localization. The region spanning amino acid residues 278 to 298
localized to the cytoplasm in 90% of transfected cells. Thus, the
p44(278–298) fragment is a functional NES, designated NES2.
Indeed, sequence analysis indicated that there is a leucine-rich
sequence in this region (Figure 4B) that resembles the classical
leucine-rich NES [15]. As expected, mutations on L280 or/and
L283 abolished NES2 activity (Figure 3A). Thus, NES2 is a
conventional leucine-rich NES.
Three functional NLS found in p44/WDR77
Sequence deletion analysis indicated that three regions (amino
acid residues 1–124, 120–260, and 220–342) contain NLS signals
(Figure 3A). Deletion of amino acid residues 1 to 48 from the N-
terminal end or of five amino acid residues (120 to 124) from the
C-terminal end of the p44(1–124) fragment did not affect the NLS
activity. Further deletion from either end resulted in complete loss
of nuclear localization. The protein fragment p44(49–119) was
found within the nucleus in 95% of transfected cells. Thus, the 49
to 119 region has nuclear targeting activity and an NLS (NLS1)
was identified that does not resemble any known NLS (Figure 4B).
Deletion to amino acid residue 165 from the N-terminal end or
to amino acid residue 185 from the C-terminal end of p44(120–
260) did not affect nuclear localization (Figure 3A). However, the
region from 165 to 185 does not have any detectable NLS activity.
Inclusion of 21 amino acid residues (144 to 164) at the N-terminal
end or 12 amino acid residues (186 to 197) at the C-terminal end
partially restored NLS activity. The protein fragment p44(144–
197) was found within the nucleus in 98% of transfected cells.
Thus, NLS2 spans the region of amino acid residues 144 to 197
and is a novel NLS (Figure 4B).
Similar analysis defined a third NLS, NLS3, which contains
amino acid residues 220 to 274 (Figure 3A). Amino acid residues
272SL
274 are critical for nuclear targeting of p44(220–274), since
deletion or mutation (
272SL
274 to
272GG
274) of two amino acid
residues led to complete loss of nuclear localization. This NLS is
novel and does not resemble any known NLS (Figure 4B).
Western blot analysis with anti-FLAG antibody was used to detect
expression and stability of all f:GFP-p44 truncations in Cos 7 cells (ten
f:GFP-p44 truncations are shown in Figure 3B). The positions in the
p44/WDR77 molecule and sequences of these identified nuclear
export and import signals are shown in Figures 4A and 4B,
respectively. The subcellular localization of identified nuclear
transport signals in Cos 7 cells is shown in Figure 5.
Mechanisms that control subcellular localization of
p44/WDR77
Multiple nuclear transport signals within a protein may act
through complicated (cooperating or antagonizing) mechanisms to
determine its intracellular localization. Treatment of transfected cells
with leptomycin B (LMB), a compound that specifically inhibits the
leucine-rich NES by blocking CAM1 activity and results in
accumulation of NES-containing proteins in the nucleus [15],
blocked cytoplasmic localization of NES2 (Figure 6A, middle panels),
as expected, but did not affect the activity of NES1 (Figure 5A, left
panels). LMB treatment did not affect cytoplasmic localization of
p44/WDR77 in LNCaP cells (Figure 6A, right panels), suggesting
that NES1 is sufficient to determine cytoplasmic localization of p44/
WDR77. Moreover, the mutation (L287A/L290A) that abolished
NES2 activity did not affect the cytoplasmic localization of p44/
WDR77 in LNCaP cells (data not shown).
To evaluate the combinatorial effect of the identified nuclear
transport signals, a series of p44/WDR77 protein fragments
containing various numbers of NES, NLS, or both NES and NLS
were generated (Figure 6B). The fragment p44(49–165), which
contains NLS1 and NES1, was found in both nucleus and cytoplasm
in 93% of transfected Cos 7 cells, indicating that these two signals
antagonize each other. Addition of NLS2 to this fragment did not
change its subcellular localization, but the region p44(49–274), which
contains NLS1, NES1, NLS2, and NLS3, showed exclusive nuclear
localization in 98% of transfected Cos 7 cells, suggesting that these
three NLS signals act cooperatively to overcome NES1 activity. The
region p44(114–197), containing NES1 and NLS2, and the region
p44(114–278), containing NES1 and NLS2 and NLS3, showed
cytoplasmic localization in 87% or 100% of cells, respectively,
indicating that NES1 is dominant over NLS2 and NLS3. In contrast,
the region p44(220–298), containing NLS3 and NES2, localized in
the nucleus in 97% of cells, suggesting that NLS3 is dominant over
NES2. The fragment p44(49–298) contains all identified nuclear
transport signals (NES1, NES2,N L S 1 ,N L S 2 ,N L S 3 )a n ds h o w e d
both nuclear and cytoplasmic localization in 99% of transfected cells.
Inclusion of the N-terminal 48 amino acid residues (1–48) did not
affect subcellular localization, but the fragments p44(49–342) and
p44(49–300) localized in the nucleus in more than 90% cells, a
proportion similar to that achieved by the full-length p44/WDR77
protein. This observation indicates that the amino acids residues
299FV
300 play a critical role in determining the nuclear localization of
the fragment p44(49–300). Mutation of
299FV
300 to
299AA
300
completely abolished nuclear localization of p44(49–300) and full-
length p44 (Figures 6B,C).
We generated a panel of point mutations within the 49–119
region of NLS1 and found that three residue mutations (L49A,
Q78K, and E91K) would abolish NLS1 activity and result in
cytoplasmic localization of p44/WDR77 in Cos7 cells (Figure 6C).
Nuclear localization is required for p44/WDR77 function
in AR-driven transcription
Since p44/WDR77 enhances AR-driven gene transcription [1],
the effect of mutations (F299A/V300A, L49A, Q78A, or E91K)
show cytoplasmic localization of GFP-p44/WDR77 in the stable LNCaP cell line expressing GFP-p44/WDR77 (top panel) and subcellular localization of
GFP in Cos 7 cells (bottom panel). The fluorescence intensity changes across the white line in the direction of the arrowhead were plotted as the line
intensities in the histogram (ImageJ, NIH) at the right side. The red line represents the intensities of nuclear staining.
doi:10.1371/journal.pone.0022395.g002
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PLoS ONE | www.plosone.org 5 July 2011 | Volume 6 | Issue 7 | e22395Figure 3. Mapping of nuclear transport signals in the p44/WDR77 molecule. (A) Diagrams of the p44/WDR77 truncations expressed as GFP-
fusion proteins in Cos 7 cells. The percentages of cells with GFP-p44/WDR77 truncations in cytoplasm (C), nucleus (N), or cytoplasm plus nucleus (C/N)
are shown on the right. (B) Western blot analysis of whole-cell extracts derived from Cos 7 cells transfected with pcDNA-f:GFP-p44/WDR77 truncations
(lanes 2–11) with anti-FLAG antibody. Lane 1 is the whole-cell lysate from nontransfected Cos 7 cells.
doi:10.1371/journal.pone.0022395.g003
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dependent transcription was investigated using a transient
transfection assay. We co-transfected the luciferase reporter
plasmid containing four tandem copies of the androgen-response
elements (AREs) derived from the PSA gene upstream of the
minimal adenovirus E4 promoter [23–25] with expression vectors
for AR and wild-type or mutant GFP-p44/WDR77 fusion
proteins into Cos 7 cells in the presence of the synthetic androgen
R1881. As shown in Figure 7A (left panel), AR activated the
reporter about 3-fold, and co-expression of wild-type GFP-p44
enhanced (,6-fold) this AR-dependent transactivation. This result
was consistent with our previous findings [1]. In contrast, co-
expression of mutant (F299A/V300A, L49A, Q78A, or E91K)
GFP-p44/WDR77 failed to increase this reporter activity. Similar
results were obtained with a natural (Probasin) AR reporter
(Figure 7A, right panel). Western blot analysis indicated that the
Figure 4. (A) Diagram shows the identified NES (NES1, NES2) and NLS (NLS1, NLS2, NLS3) in human p44/WDR77 protein. The seven
WD40 repeats are indicated. (B) Amino acid sequences of identified nuclear transport signals and sequence alignment of NES2 with the consensus of
the leucine-rich NES.
doi:10.1371/journal.pone.0022395.g004
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at similar levels (Figure 7B). Endogenous p44/WDR77 and b-
actin were used as loading controls. Western blot analysis of
cytoplasmic and nuclear fractions of transfected cells revealed that
wild-type GFP-p44/WDR77 localized mainly in the nucleus and
that mutation (F299A/V300A, L49A, Q78A, or E91K) of p44/
WDR77 abolished its nuclear localization (Figure 7C). Thus,
nuclear localization is required for the p44/WDR77 function in
AR-driven transcription.
The identified nuclear localization signals do not function
in AR-positive prostate cancer cells
To test whether the identified nuclear transport signals function
in prostate cancer cell lines (LNCaP, PC3, 22RV1), we performed
localization assays using constructs expressing GFP-fusion proteins
of NES1, NES2, NLS1, NLS2, and NLS3. All nuclear transport
signals functioned similarly in AR-negative PC3 (Figure 5A,
middle panels) and Cos 7 cells (Figure 5A, left panels). GFP-NES1
and GFP-NES2 were localized in the cytoplasm in LNCaP
Figure 5. Subcellular localization of isolated nuclear export and import signals in Cos 7, PC3, and LNCaP cells. (A) Cells were
transfected with pcDNA-f:GFP-NES1, -NES2, -NLS1, -NLS2, or -NLS3 and observed under a confocal microscope. (B) Western blot of cytoplasmic and
nuclear fractions of the transfected cells described in (A) with anti-FLAG, anti-HSP90, or anti-lamin B antibody.
doi:10.1371/journal.pone.0022395.g005
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PLoS ONE | www.plosone.org 8 July 2011 | Volume 6 | Issue 7 | e22395Figure 6. The relationship between identified nuclear export and import signals. (A) LMB does not inhibit translocation of p44/WDR77 to
the cytoplasm. Cos 7 cells were transfected with pcDNA-GFP-NES1 or -NES2 (left two panels). The transfected cells were grown in the presence of
dimethylsulfoxide (DMSO) or 20 mM of LMB for 6 hr. Subcellular localization of GFP-NES1 and GSP-NES2 was observed under a confocal microscope.
Cos 7 cells were grown in the presence of DMSO or 20 mM of LMB for 6 hr and immunostained with the anti-p44 antibody (right panel). (B) Cos 7 cells
were transfected with constructs expressing GFP-fusion proteins of various p44/WDR77 truncations or point mutations as indicated. The transfected
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However, the GFP-fusion proteins of NLS1, NLS2, and NLS3
failed to localize in the nucleus of these cells (Figure 5A, right
panels), indicating that these nuclear localization signals lost
function in AR-positive LNCaP and 22RV1 cells. Western blots of
cytoplasmic and nuclear fractions further confirmed the subcellu-
lar localization of identified nuclear transport signals in Cos 7,
PC3, and LNCaP cells (Figure 5B).
We then performed interspecies heterokaryon assays [26,27] to
investigate whether LNCaP cells express a factor that inhibits the
function of nuclear localization signals or is lacking a factor that is
essential for the function of these signals. Cos 7 cells were
transiently transfected with pcDNA-GFP-p44 or pcDNA-GFP-
NLS1 (Figure 8A). Twenty-four hours after transfection, untrans-
fected human LNCaP cells were co-cultured and fused with the
transfected Cos 7 cells to form heterokaryons. To distinguish
between human LNCaP and monkey Cos 7 nuclei, the cells were
stained with TO-PRO 3. Six hours after cell fusion, GFP-p44 and
GFP-NLS1 localized in both human (Figure 8A, small nuclei
indicated by white arrows) and monkey nuclei. This indicates that
LNCaP cells are lacking the factor or signal that is required for
function of p44/WDR77 nuclear localization signals. To confirm
this finding, we performed the in vitro transportation assay (Figure
S6). Whole-cell extracts were made from PC3 or LNCaP cells and
added to cultured LNCaP or PC3 cells. The whole-cell lysate
derived from LNCaP cells did not affect the nuclear localization of
the full-length p44/WDR77 protein in PC3 cells, whereas the
whole-cell lysate derived from PC3 cells switched the localization
of p44/WDR77 from cytoplasm to nucleus in LNCaP cells. As a
negative control, the PC3-derived whole-cell lysate did not affect
subcellular localization of GFP in LNCaP cells. These analyses
confirmed that LNCaP cells lack the factor(s) that is required for
the function of the identified nuclear localization signals.
Polypeptides associated with NLS1 and NES1 in prostate
cancer cells
To identify proteins that are involved in nuclear transport of
NLS1 and NES1, we established three stable PC3 cell lines that
express the FLAG epitope-tagged GFP-NLS1 (f:GFP-NLS1), or
GFP-NES1 (f:GFP-NES1). f:GFP-NES1 mainly localized in the
cytoplasm (Figure 8B, top panels), while f:GFP-NLS1 was found
largely in the nucleus (bottom panels) in the stable PC3 cell lines.
Large amounts (50 ml for each cell line) of cytoplasm (S100) and
nuclear (NE) extracts were prepared from f:GFP-NLS1 and f:GFP-
NES1 cell lines and were submitted for immunoprecipitation using
M2 agarose. After elution with the FLAG peptide, the immuno-
purified proteins were analyzed by SDS-PAGE and stained with
Coomassie Brilliant Blue R-250 (Figure 8C; bands corresponding
to f:GFP-NES1 and f:GFP-NLS1 are indicated by black arrows
[lanes 2–5]). Polypeptides that were specifically associated with
f:GFP-NLS (lane 3) but not with f:GFP-NES1 (lane 2) in the
nucleus and those that were associated with f:GFP-NES1 (lane 4)
in the nucleus but not with NLS1 (lane 5) in the cytoplasm were
marked by numbers (1-10) and stars and submitted for mass
spectrometric (MALDI-TOF/TOF) analysis.
Two of the polypeptides (lane 3) are the degraded products of
f:GFP-NLS1, and the other identified polypeptides are listed in
Table 1. Eight polypeptides were specifically associated with
f:NLS1 but not f:GFP-NES1 in the nucleus. DEAH box protein 9
(DHX9) and DEAD box protein 21 (DDX21) are RNA helicases
that have been shown to function as transcriptional cofactors for
BRCA1-, CREBBP-, NF-kB-, and JUN-activated transcription
[28–31]. Association of these two proteins with f:GFP-NLS1 in the
nucleus indicates that they may be involved in p44-mediated
transcription. In the developing Xenopus embryo, nucleolin (NCL)
was localized in cytoplasm up to the midblastula stage, but
thereafter accumulated in the nucleus [32]. Nucleolin can function
as a carrier for the import and export of proteins across nuclear
membrane [33,34]. Nucleophosmin (NPM) colocalized with
nucleolin and also shuttled between cytoplasm and nucleus [35].
Nucleolin bound to histone H1 and induced chromatin decon-
densaion [36,37]. Histone H1 (H1.3, H1t, H1.4, H1.2) found in
the f:GFP-NLS1 complex may associate with nucleolin. Three
polypeptides (LDH A chain, tumor protein D54, and heat shock
protein b-1) were specifically associated with f:GFP-NES1 but not
with f:GFP-NLS1 in the cytoplasm. The function of tumor protein
D54 (TP52L) is unknown. The mRNAs of DHX9, DDX21, NCL,
NPM, and TP52L were detected in LNCaP and PC3 cells (Figure
S7).
Discussion
The functional activity of p44/WDR77, an important regulator
of AR functions during prostate gland development and prostate
tumorigenesis [1–4], is controlled by its subcellular localization. In
this study, we demonstrated that p44/WDR77 can localize in the
nucleus or cytoplasm and defined two NES and three NLS
sequences that are responsible for nuclear import and export of
p44/WDR77. We further found that p44/WDR77 NLS signals
are not functional in AR-positive prostate cancer cells, resulting in
accumulation of p44/WDR77 in the cytoplasm of such cells.
Importantly, regulating of p44/WDR77 cellular distribution is
independent of AR.
p44/WDR77 comprises multiple nuclear transport signals
By studying the ability of various p44/WDR77 segments that
determine nuclear or cytoplasmic localization of fused GFP, we
defined the minimum essential two NES and three NLS sequences
in the p44/WDR77 protein. A canonical NES (NES2) was
identified in the C-terminal part of p44/WDR77, and mutations
on the conserved leucine residues in NES2 that are important for
the CRM1-dependent export function abolished its nuclear export
activity. NES2 is conserved among p44/WDR77 proteins across
different species and influences cytoplasmic localization of the
fragment p44(49–278) (containing NLS1, NES1, NLS2, and
NLS3). Mutations of the critical leucine residues had no affect
on the cytoplasmic localization of full-length p44/WDR77 in
LNCaP cells, indicating that NES2 is not essential for nuclear
export of the full-length protein. In support of this finding was the
observation that LMB, which inhibited nuclear export of isolated
NES2, did not affect cytoplasmic localization of p44/WDR77 in
LNCaP cells. One novel NES (NES1) was defined as a 52-amino-
acid fragment (amino acid residues 114–165) that partially
overlapped NLS1 (amino acid residues 49–119). NES1 functions
in a CRM1-independent manner and is sufficient to mediate
cytoplasmic export of p44/WDR77 in LNCaP cells.
cells were stained with TO-PRO 3 and observed under a confocal microscope. The percentages of cells with GFP signals in cytoplasm (C), nucleus (N),
or cytoplasm plus nucleus (C/N) are shown on the right. (C) Point mutations on p44/WDR77 abolished its nuclear localization in Cos 7 cells. Cells were
transfected with constructs expressing the wild-type or mutant (V299A/F300A, L49A, Q78K, or E91K) GFP-p44/WDR77, stained with TO-PRO 3, and
observed under a confocal microscope.
doi:10.1371/journal.pone.0022395.g006
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amino acid residues 49–119, 144–197, and 220–274. These NLS
signals are novel and do not resemble classical NLS, PY-NLS, or
other known NLS signals. Mutations (L49A, Q78K, or E91K) that
disrupt nuclear import of NLS1 are sufficient to abolish nuclear
localization of the full-length p44/WDR77 in Cos 7 cells,
indicating that the nuclear localization of p44/WDR77 is
determined mainly by NLS1.
Mechanisms for p44/WDR77 transport between
cytoplasm and nucleus
The mechanism for p44/WDR77 nuclear translocation is
further elucidated by the fragments that contain the identified
nuclear transport signals. The nuclear export of NES2 or nuclear
import of NLS2 and NLS3 is weak when compared to that of
NES1 or NLS1. Fragments containing NES1 and NLS2 or/and
NLS3 (but not NLS1) accumulated in the cytoplasm, while
fragments containing NLS1 and NES2 (but not NES1) accumu-
lated in the nucleus. The fragment containing both NLS1 and
NES1 distributed equally in cytoplasm and nucleus, indicating
comparable nuclear transport activities.
The C-terminal region (299–342) does not contain any nuclear
export or import activity when fused to GFP. Interestingly,
residues 299-300 could change the cytoplasmic localization of
regions p44(49–298) and p44(1–298) to the nucleus, and mutation
(V299A/F300A) abolished this activity. These results suggest that
amino acid residues V299 and F300 play a critical role in nuclear
localization of p44/WDR77. Understanding the exact mechanism
of how these residues regulate subcellular localization of p44/
WDR77 will require further investigation. One possibility is that
these residues somehow modulate the nuclear import functions of
p44/WDR77 by masking or sequestering the NES1 signal.
The subcellular localization of p44/WDR77affects its
function
Our studies revealed distinct subcellular localization of p44/
WDR77 during mouse prostate development. During the early
stage of prostate development, p44/WDR77 localizes in the
cytoplasm when epithelial cells are rapidly dividing. In the adult
prostate, p44/WDR77 is resident in the nucleus of fully
differentiated epithelial cells. These observations led to the idea
that nuclear p44/WDR77 is required for differentiation of
prostate epithelial cells. This may be especially important during
early prostate development when the p44/WDR77 function in
differentiation is not required. Consistent with this notion was our
finding that loss of the p44/WDR77 gene resulted in loss of
differentiation of prostate epithelium [4]. It is also possible that
cytoplasmic p44/WDR77 functions to control cell growth, based
on its presence in complexes that are involved in splicing.
While p44/WDR77 is resident in the nucleus of benign prostate
epithelial cells, it localizes to the cytoplasm in prostate cancer cells.
This translocation event occurs in hyperplastic epithelial cells.
Forced nuclear localization of p44/WDR77 inhibited proliferation
of prostate cancer cells [2,3]. These observations suggest that
nuclear p44/WDR77 inhibits cell growth and is associated with
differentiation while its translocation to cytoplasm relieves this
inhibition. Nuclear import of isolated NLS signals is defective in
AR-positive prostate cancer (LNCaP and 22RV1) cells, leading to
sequestering of p44/WDR77 into cytoplasm and relieve p44/
WDR77-mediated growth inhibition.
Taken together, the results of this study provide several new
insights into the molecular mechanisms governing nuclear and
cytoplasmic localization of p44/WDR77. These data also provide
important tools for further investigation of the signaling pathways
controlling subcellular localization of p44/WDR77 during pros-
tate development and prostate tumorigenesis. Identification of
proteins that are specifically associated with NLS1 and NES1
would allow us to further investigate how these proteins are
involved in the control of subcellular localization of p44/WDR77.
The nucleophosmin gene is one of the most frequent targets of
mutation, deletion, and chromosome translocation associated with
a variety of human cancers [35]. Alteration or loss of
nucleophosmin function is suggested to cause unregulated cell
growth and proliferation. Of particular interest would be
investigation of whether LNCaP cells have altered nucleophosmin,
which would explain the cytoplasmic localization of p44/WDR77.
Materials and Methods
Prostate gland preparation and immunostaining
Experiments in mice were conducted according to NIH
guidelines and approved by the Institutional Animal Care and
Use Committee (IACUC #01-02-00134) at The University of
Texas MD Anderson Cancer Center. Male mice (B57/CL) aged 7,
14, 28, 32, and 45 days were killed and the prostate glands were
freed from the other structures. The prostate glands were removed
en bloc (including the seminal vesicles, urethra, and bladder) and
fixed with 4% paraformaldehyde in phosphate-buffered saline
solution (PBS) at 4uC overnight and embedded in paraffin.
Sections (4 mm) were cut and mounted on Super-frost Plus
adhesion slides (Fisher). Antigen-purified anti-p44/WDR77 anti-
body (1:100) [1] was applied to the prostate tissue sections and
incubated overnight. Alexa 594-labeled anti-rabbit immunoglob-
ulin G antibody (1:1,000) (DAKO) was used as the second
antibody. The nucleus was stained with SYTOX Green. The
fluorescent signals were observed under a confocal microscope
with a red (to detect the p44/WDR77 protein) or green (to detect
the nucleus) filter.
DNA constructs and reagents
The p44/WDR77 gene fragments were amplified from the
pcDNA-p44/WDR77 construct [1] using specific primer pairs
with appropriate restriction sites. The DNA fragment encoding
the GFP, derived from pEGFP-N1 (Clontech), was subcloned into
pcDNA3.1 to generate the pcDNA-f:GFP construct. The cDNA
encoding human p44/WDR77 or a p44/WDR77 truncation was
subcloned into pcDNA-f:GFP to express the N-terminal f:GFP-
fusion proteins of p44/WDR77 or p44/WDR77 truncations. Site-
directed mutagenesis was performed according to the Quick-
Change site-directed mutagenesis kit protocol (Stratagene). All
constructs were verified by restriction enzyme digestion and by
DNA sequencing. Methyltrienolone (R-1881) and LMB were
obtained from NEN and LC Laboratories, respectively.
fmoles of pcDNA-f:GFP-p44 or pcDNA-f:GFP-p44mt. Transfected cells were grown in the presence of 10 nM R1881 for 48 hr and then harvested for
luciferase assay. Values represent mean 6 SD (n=3). (B) Western blot analysis of whole-cell lysates (10 mg proteins per sample) derived from the
transfected cells with the anti-p44 (top) or anti-actin (bottom) antibody as indicated. The transfected GFP-p44 fusion protein, endogenous p44
protein, and b-actin are indicated by arrows on the right. (C) Western blot of cytoplasmic and nuclear fractions of the transfected cells described in (A)
with anti-FLAG, -HSP90, or anti-lumin B antibody.
doi:10.1371/journal.pone.0022395.g007
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LNCaP, PC3, 22RV1, BPH1, and Cos 7 cell lines were
obtained from American Type Culture Collection and maintained
in RPMI 1640 medium with 10% fetal bovine serum. Cells were
grown on chamber slides, fixed with cold methanol (220uC) for
10 min, and immunostained with the anti-p44/WDR77 antibody.
The Alexa-555-label second antibody (Molecular Probes) was
used. After washing, cells were stained with TO-PRO 3 (10 mg/
ml) (Molecular Probes), mounted in Histogel (Linaris), and
analyzed directly by fluorescence confocal microscopy. Transfec-
Figure 8. Cos 7 cells restore p44/WDR77 nuclear localization in LNCaP cells. (A) LNCAP cells were transfected with pcDNA-GFP-p44/WDR77
or pcDNA-GFP-NLS1. After expression of the transfected DNAs, the cells were fused to Cos 7 cells to form heterokaryons. After incubation for 6 hr, the
cells were fixed and counterstained with TO-PRO 3, which differentiates the human and monkey nuclei within the heterokaryon (arrows identify the
human nuclei). The panel marked Bright shows the phase-contrast image of the heterokaryons; the broken line highlights the cytoplasmic edge. (B)
Cytoplasmic localization of f:GFP-NES1 and nuclear localization of f:GFP-NLS1 in PC3 cells. PC3 cells stably expressing f:GFP-NES1 (top panels) or f:GFP-
NLS1 (bottom panels) were stained with TO-PRO 3 and observed under a confocal microscope. (C) Identification of polypeptides that were associated
with NES1 or NLS1. The bands corresponding to f:GFP-NES1 and f:GFP-NLS1 are indicated by arrows. Polypeptides specifically associated with f:GFP-
NLS1 or f:GFP-NES are indicated by numbers and stars. The standard protein markers (Bio-Rad) are shown in lane 1.
doi:10.1371/journal.pone.0022395.g008
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reagent (Invitrogen) according to the manufacturer’s instructions.
The cells were fixed 24 hr after transfection with cold methanol for
10 min, stained with TO-PRO 3 for 30 min, and analyzed by
fluorescence confocal microscopy with a green (to detect the GFP or
GFP-p44 fusion proteins) or red (to detect the nucleus counter-stained
with TO-PRO 3) filter. For treatment with LMB, cells were grown in
the presence of dimethylsulfoxide (control) or LMB (20 mM) for 6 hr.
Cells were fixed with cold methanol for 10 min, stained with TO-
PRO 3, and submitted for analysis.
Cytoplasmic and nuclear extract preparation
Cytoplasmic and nuclear fractions were prepared from cultured cells
by using the Nuclear Extract Kit (Catalog #40010 & 40410, Active
Motif). Briefly, cells were washed with ice-cold PBS and removed from
the dishes by gentle scraping. Cells were pelleted by centrifugation,
resuspended in 500 ml Hypotonic Buffer, and incubated for 15 min on
ice. Twenty-five microliter of Detergent was added and the sample was
subjected to vortexing for 10 s at the highest setting. The cell lysate was
subjected to centrifugation for 30 s at 14,0006g at 4uCa n dt h e
supernatant (cytoplasmic fraction) was transferred into a microcen-
t r i f u g et u b ea n ds t o r e da t- 8 0 uC until needed. The nuclear pellet was
resuspended in 50 ml Complete Lysis Buffer subjected to vortexing for
10 s, incubated for 30 min on ice, and subjected to centrifugation for
10 min at 14,0006g at 4uC. The supernatant (nuclear fraction) was
transferred into a microcentrifuge tube and stored at 280uC.
Heterokaryon assay
Interspecies heterokaryons of human LNCaP cells and monkey
Cos 7 cells were formed according to the previously described
method [38,39]. Briefly, Cos 7 cells were transiently transfected
with plasmid DNA (pcDNA-f:GFP-p44/WDR77 or pcDNA-
f:GFP-NLS1). Twenty-four hours after transfection, nontrans-
fected human LNCaP cells were co-plated with the transfected
Cos 7 cells at a 2:1 ratio and co-cultured for 18 hr. The co-
cultured cells were fused with PEG6000 at 23uC for 5 min. Fused
cells were washed with PBS and incubated at 37uC for an
additional 6 hr. The cells were fixed with cold methanol for
10 min and counterstained with TO-PRO 3 to distinguish
between human LNCaP and monkey Cos 7 cell nuclei.
In vitro transport assay
In vitro transport assay was performed as described previously
[40]. Briefly, LNCaP or PC3 cells were transiently transfected with
pcDNA-f:GFP or pcDNA-f:GFP-p44/WDR77. Eighteen hours
after transfection, cells were subjected to permeabilization with
digitonin (55 mg/ml) and incubated for 30 min at 23uC with
bovine serum albumin (20 mg/ml) or with whole-cell lysate of
LNCaP or PC3 cells in transport buffer [20 mM Hepes, pH 7.4,
110 mM potassium acetate, 5 mM NaCl, 2 mM MgCl2,1m M
EGTA, 1 mM dithiothreitol, 1 mM ATP, 10 mM creatine
phosphate, 4 units/ml phosphokinase, and protease inhibitor
cocktail (Sigma-Aldrich)]. The cells were fixed with cold methanol
for 10 min, counterstained with TO-PRO 3, and observed under
a confocal microscope.
Luciferase assay
The pGL3-4xARE-E4-luc luciferase report contains four
tandem copies of AREs of the PSA gene, upstream of the minimal
adenovirus E4 promoter and the pGL3-Probasin-luc reporter
contains the Probasin promoter from 2244 to +24 [41–45]. Cos 7
cells (1.6610
4 cells/well) were plated into 24-well plates and
transfected 24 hr later with 25 fmoles of a luciferase reporter
plasmid, 0.8 fmoles of a pRL-LUC internal control plasmid, and
indicated amounts of expression plasmids. The total amount of
DNA was adjusted to 75 fmoles using pcDNA3.1. The transfection
was conducted using Lipofectamine (Invitrogen) in serum- and
phenol red-free RPMI 1640 medium. After 6 hr of transfection,
the medium was exchanged for phenol red-free RPMI 1640
medium plus 10% dextran/charcoal-stripped fetal bovine serum
and R-1881 (10 nM). Cells were cultured for another 48 hr and
harvested for analysis in a dual luciferase assay (Promega). Three
independent experiments were performed for each transient
transfection assay, and results are presented as mean 6 SD (n=3).
Establishment of PC3 lines that stably expressed a FLAG-
tagged GFP-NLS1 or GFP-NES1 and immunopurification
of f:GFP-NLS12 and f:GFP-NES12associated proteins
PC3 cells were transfected with pcDNA-f:GFP, pcDNA-f:GFP-
NLS1, or pBabe-f:GFP-NES1 and further incubated at 37uC for
1–1.5 days before being split 1:6 for G418 selection (0.5 mg/ml).
The medium was changed every 3 or 4 days. Individual G418-
resistant colonies, normally seen after 2 weeks, were expanded into
cell lines and then characterized by western blotting using the anti-
FLAG M2 monoclonal antibody (Sigma-Aldrich). The cell lines
expressing FLAG-tagged GFP, GFP-NLS1, or GFP-NES1 were
further expanded and analyzed. Nuclear and cytoplasmic extracts
were prepared according to our standard methods [46] from 200
Table 1. Proteins associated with NLS1 or NES1 in PC3 cells.
Sample ID Protein Name Accession No. Protein MW Peptide Counts
1 DEAH box protein 9 Q08211.4 140 29
2 Nucleolin P19338.3 105 14
3 DEAD box protein 21 Q9NR30.5 100 26
4 Nucleophosmin P06748.2 40 8
5 Histone H1.3/H1t P16402/P22492.4 35 9/5
6 Histone H1.4 P10412 33 12
7 Histone H1.2 P16403 32 15
8 LDH A chain P00338.2 36 12
9 Tumor protein D54 O43399.2 32 6
10 Heat shock protein ß-1 P04792.2 30 8
doi:10.1371/journal.pone.0022395.t001
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NLS12 or f:GFP-NES12containing complexes. Typically, 1 ml
of nuclear or cytoplasmic extract was mixed with 10 mlo fM 2
agarose (Sigma-Aldrich) and incubated for 3 hr at 4uC with
rotation. After five washings in 1 ml of a buffer containing 20 mM
HEPES (pH 7.9), 0.2 mM EDTA, 20% glycerol, 2 mM dithio-
threitol, 300 mM KCl, and 0.1% NP40, the bound proteins were
eluted from the M2 agarose by incubation at 4uC for 30 min with
10 ml of the same buffer plus 0.2 mg/ml of the FLAG peptide
(Asp-Tyr-Lys-Asp-Asp-Asp-Asp-Lys). The purified proteins were
precipitated with 10% trichloroacetic acid and loaded onto a 12%
polyacrylamide gel for SDS-PAGE. Proteins were visualized by
silver or Coomassie Brilliant Blue R-250 staining. Protein bands
were cut and sent to the Mass Spectrometry Laboratory (MD
Anderson Cancer Center) for MALDI-TOF/TOF analysis.
Real-time polymerase chain reaction
Total RNAs were isolated from LNCaP and PC3 cells by the
TRIzol Reagent and reverse-transcribed by using the Reaction
Ready First Strand cDNA Synthesis Kit (SuperArray Bioscience
Corp.). The resulting cDNA products were PCR-amplified (40
cycles of 30 s at 94uC; 20 s at 55uC; 30 s at 72uC) with the RT
2
real–time SyBRgreen PCR master mix and the gene-specific
primer sets for human DXH9, DDX21, NCL, NPM, TP52L, and
b-actin (SuperArray Bioscience Corp.) by the SmartCycler II
(Cepheid). The raw data procession and quantification were
performed with the SmartCycler Software (Version 2.0C). The 2
-
DDCT method was used to determine the relative quantification of
target gene expression. The relative mRNA expression =1,0006
quantification of the gene/quantification of actin.
Supporting Information
Figure S1 (A), Immunostaining of AR, CK5, and Ki67 in
prostate glands derived from mice age 7, 14, 28, 32, 45 days. The
alkaline phosphophase - labeled anti-rabbit immunoglobulin G
antibody was used. (B), The percentage of Ki67-positive epithelial
cells in prostate glands derived from mice age 7, 14, 28, 32, 5 days.
(TIF)
Figure S2 Western blot of cytoplasmic and nuclear fractions of
Cos 7, LNCaP, and PC3 cells with anti -p44 (top), -HSP90
(middle), or -lamin B antibody.
(TIF)
Figure S3 P44 physically interacts with AR. GST (lanes 2, 8,
and 13) or GST-p44 truncations, immobilized on beads, were
mixed with 5 ml of in vitro labeled AR. After washing the beads,
the bound proteins and 10% of the input (lanes 1, 7, 12) were
analyzed on 8% SDS-PAGE and visualized by autoradiography.
(TIF)
Figure S4 (A), AR expression in prostate cancer cell lines.
Western blot with anti-p44, -AR, and -actin antibodies were
performed using whole-cell lysates made from Cos 7, LNCaP,
PC3, and PC3-AR cells. (B), Ligand-dependent nuclear translo-
cation of AR. LNCaP and PC3-AR cells were grown in the
absence or presence of 10 nM R1881overnight and submittedfor
AR immunostaining. The nucleus was stained with TO-PRO 3
and the fluorescent signals were observed under a confocal
microscope.
(TIF)
Figure S5 Subcellular localization of p44 was not affected by the
androgen. LNCaP and PC3-AR cells were grown in the absence
or presence of 10 nM R1881overnight and submitted for p44
immunostaining. The nucleus was stained with TO-PRO 3 and
the fluorescent signals were observed under a confocal microscope.
(TIF)
Figure S6 Restoration of p44/WDR77 nuclear localization in
LNCaP cells by PC3 whole-cell lysate. LNCaP and PC3 cells were
transfected with pcDNA-GFP-p44/WDR77 or pcDNA-GFP.
After 24 hr, the cells were washed and incubated with whole-cell
lysate derived from LNCaP or PC3 cells as indicated. The
fluorescent signals were observed under a confocal microscope.
(TIF)
Figure S7 Expression of identified factors in PC3 and LNCaP
cells. Total RNAs were isolated from LNCaP and PC3 cells and
submitted for RT-PCR analysis with primers specific for identified
factors.
(TIF)
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